Pharma, PBMs spar over rising drug costs amid public scrutiny
Nadzeya Haroshka The top pharmaceutical lobby group, PhRMA, and drug middlemen known as pharmacy benefit managers (PBM) have resumed their ...
Nadzeya Haroshka The top pharmaceutical lobby group, PhRMA, and drug middlemen known as pharmacy benefit managers (PBM) have resumed their ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.